Emergent BioSolutions Inc (EBS)
8.10
+0.04
(+0.50%)
USD |
NYSE |
Dec 20, 16:00
8.12
+0.02
(+0.25%)
After-Hours: 20:00
Emergent BioSolutions Total Assets (Quarterly): 1.478B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 74.36B |
| Tonix Pharmaceuticals Holding Corp | 94.99M |
| Chimerix Inc | 158.67M |
| Geron Corp | 444.95M |
| MAIA Biotechnology Inc | 9.243M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 969.40M |
| Shareholders Equity (Quarterly) | 508.40M |
| Debt to Equity Ratio | 1.303 |
| Current Ratio | 2.877 |
| Net Debt Paydown Yield | 10.66% |